Cargando…
New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia
Among infectious diseases, tuberculosis is the leading cause of death worldwide, and represents a serious threat, especially in developing countries. The protective effects of Bacillus Calmette-Guerin (BCG), the current vaccine against tuberculosis, have been related not only to specific induction o...
Autores principales: | Tarancón, Raquel, Domínguez-Andrés, Jorge, Uranga, Santiago, Ferreira, Anaísa V., Groh, Laszlo A., Domenech, Mirian, González-Camacho, Fernando, Riksen, Niels P., Aguilo, Nacho, Yuste, José, Martín, Carlos, Netea, Mihai G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117655/ https://www.ncbi.nlm.nih.gov/pubmed/32240273 http://dx.doi.org/10.1371/journal.ppat.1008404 |
Ejemplares similares
-
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice
por: Aguilo, Nacho, et al.
Publicado: (2016) -
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
por: Gonzalo-Asensio, Jesus, et al.
Publicado: (2017) -
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
por: Broset, Esther, et al.
Publicado: (2019) -
Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination
por: Vierboom, Michel P.M., et al.
Publicado: (2021) -
Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis
por: Roy, Alvaro, et al.
Publicado: (2019)